| Overview |
| bsm-90092r-50µL |
| ACBD3 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human ACBD3 |
| 1-61/528 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 64746 |
| Q9H3P7 |
| ACBD3; Acyl-CoA Binding Domain Containing 3; GCP60; PBR- And PKA-Associated Protein 7; GOCAP1; GOLPH1; PAP7; Peripheral Benzodiazepine Receptor-Associated Protein PAP7; Acyl-Coenzyme A Binding Domain Containing 3; Golgi Complex Associated Protein 1 60kDa; Golgi Resident Protein GCP60; Golgi Phosphoprotein 1; Acyl-CoA-Binding Domain-Containing Protein; Golgi Complex-Associated Protein 1; PKA (RIalpha)-Associated Protein |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |